A Phase I Study of the Mammalian Target of Rapamycin Inhibitor Sirolimus and MEC Chemotherapy in Relapsed and Refractory Acute Myelogenous Leukemia
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-09-0842
Full Text
Open PDFAbstract
Available in full text
Date
October 20, 2009
Authors
Publisher
American Association for Cancer Research (AACR)